Community Acquired Pneumonia (CAP)

Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia

Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia

Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care

Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)

Effect of tNGS on CAP Patients With Initial Treatment Failure

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

Lower Respiratory Tract Infections Managed in Primary Care in France

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults

Evaluation of Physical Capacity and Energy Requirements in Patients With Hypoxemic Acute Respiratory Failure

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)

OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

Kinetics and Metabolism of Nicotinamide Provided as a Dietary Supplementation

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

Pneumonia Pathogens' Virulence Factors, Patient Inflammatory Markers, and Their Associations With Outcomes

Local Antibiotic Delivery for Community Acquired Pneumonia

Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)

Ketek in CAP / AECB in Ambulatory Adult Patients